Showing results (831-840 of 2,872) with videos related to
Sort By:
Pageof 288
Molecular Diversity|November 17, 2020
Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Sunday Solomon Josiah, et al.Molecular Diversity|October 20, 2020
Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitorsHemlata Pundir, Tanuja Joshi, Tushar Joshi, et al.Molecular Diversity|September 5, 2020
Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancerNitish Kumar, Harmandeep Kaur Gulati, Aakriti Sharma, et al.Molecular Diversity|September 15, 2020
Synthesis of 1,2,3-triazolyl nucleoside analogues and their antiviral activityOlga V Andreeva, Bulat F Garifullin, Vladimir V Zarubaev, et al.Molecular Diversity|March 7, 2020
Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studiesZeinab Abbasi-Radmoghaddam, Siavash Riahi, Sajjad Gharaghani, et al.Molecular Diversity|February 2, 2020
DNA interaction, in vivo and in vitro cytotoxicity, reactive oxygen species, lipid peroxidation of -N, S donor Re(I) metal complexesReena R Varma, Juhee G Pandya, Jyoti Sharma, et al.Molecular Diversity|February 2, 2020
A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking studyNabeel A Abdul-Rida, Ali M Farhan, Najim A Al-Masoudi, et al.Molecular Diversity|March 14, 2020
Modeling and insights into molecular basis of low molecular weight respiratory sensitizersXueyan Cui, Rui Yang, Siwen Li, et al.Molecular Diversity|March 14, 2020
Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonistsHany G Ezzat, Ashraf H Bayoumi, Farag F Sherbiny, et al.Molecular Diversity|December 4, 2019
Synthesis and molecular docking studies of novel pyrimidine derivatives as potential antibacterial agentsXue-Qian Bai, Chun-Shi Li, Ming-Yue Cui, et al.Pageof 288